← All trials
NCT04936126
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 7, 2021
- Primary completion
- Jul 7, 2024
- Completion date
- Sep 7, 2024
- First posted
- Jun 23, 2021
- Last posted
- Jun 30, 2021
- Enrollment
- 150
- Arms / groups
- 3 / —
- Source
- AACT · ingestion pipeline
Sponsors
- All India Institute of Medical SciencesLead sponsor
- All India Institute of Medical SciencesReponsible party - principal investigator
- All India Institute of Medical SciencesStudy chair
- Indian Council of Medical ResearchCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.